Free Dinner Lecture

We invite you to join your colleagues and Janssen Pharmaceuticals on May 18, 2016 6:30pm held at Ruth Chris Pier 2, 1777 Reisterstown Rd, Pikesville, MD 21208.  The topic discussed will be Xarelto the paradigm shift of treatment in patients with Deep Vein Thombosi (DVT) and Pulmonary Embolism (PE).  The guest speaker will be Mitchell Schwartz, MD.  Please RSVP to your Janssen Rep, before May 11, 2016.   Christopher Fowble 410 207 0261 or to register online click this link http://www.medforcereg.net/SOMP94603

Legislation

Legislative Image - BillDear Maryland PAs,

On behalf of the Maryland Academy of Physician Assistants (MAPA), I would like to thank all of those PAs who were at the Board of Physicians' meeting on March 30, 2016!      YOU made a difference!

It was standing-room-only, and the physicians were quite taken aback by the presence of so many PAs in the room. As a result of the presence and Dr. Ginsberg's presentation, the BOP has done a 180-degree turn in position,

Read more...

Dine and Learn

Pfizer Cordially Invite You to Attend an Informational Program

featuring

Carlos Sydney Ince, MD

Chief of Cardiology

St. Agnes Hospital, Baltimore, MD

Reducing Stroke and Thromboembolic Risk in Patients with Nonvalvular Atrial Fibrillation (N, VAF)  and treating Venous Thromboebolism (VTE)

Wednesday June 8, 2016, 6:30pm at the Chart House, 300 Second Street, Annapolis, MD 21403

Dinner and Presentation to Follow, Hosted by Diane Bambach.

 Please RSVP via our registration portal at : WWW.pfizerrsvphcp.com

Refer to Meeting ID# EZ29039728

Legislative Update

Prescription

  It worked! As a result of your and AAPA’s advocacy efforts, the Senate HELP Committee will consider legislation tomorrow that will permit PAs and NPs to prescribe buprenorphine for the  treatment of opioid addiction.
 The amended TREAT Act (S. 1455) does not include a demonstration program. It amends federal law to
 affirmatively authorize PAs to prescribe buprenorphine, treating PAs, NPs, and physicians in the same
manner, while deferring to State law.
Before receiving a waiver to prescribe buprenorphine for the treatment of opioid addiction,
all qualified providers (PAs, NPs, and physicians) must complete 24 hours of training in the treatment and
management of opiate-dependent patients. AAPA is listed as one of the organizations who can provide
the training. Additionally, the Senate HELP Committee will consider Mental Health Reform legislation, which recognizes the interface between primary care and behavioral healthcare, as well as the critical role of PAs in behavioral healthcare through the following provisions:
*Includes PAs in the mental health career development strategic plan
*Acknowledges PAs among the healthcare providers who may serve on mental health/substance abuse advisory councils established through the legislation
*Identifies PAs with experience treating serious mental illness as potential members of a new Inter-Departmental Serious Mental Illness Coordinating Committee
*Adds PAs in the development of model programs and materials for training healthcare providers on appropriate disclosures to family, friends, or other caregivers of individuals suffering from mental illness or substance abuse disorders.

Again, thank you. Your advocacy made a difference. We look forward to continuing to work with you as this important legislation progresses.

Should you have any additional questions, comments or concerns please contact Sandy directly at sharding@aapa.org .

 

Recent Pictures

Recent News

CME at Drexel

Distinguished, world-renowned international presenters...

Read More